banner add

With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.

from NYT > Health https://ift.tt/IYaTSJU
via IFTTT

No comments

Brenna Henn Wanted to Improve Genetic Medicine. Then Her N.I.H. Grant Was Cut.

Brenna Henn had a long-term grant to study the genetic diversity of Africans and people of African descent. Then her N.I.H. funding was cut....

Theme images by PLAINVIEW. Powered by Blogger.